Enterprise Validation

Nicole Dale

AI and Neuroscience. Why Big Pharma Is Betting on the Brain

Pharmatica’s AI in neuroscience graphical concept showing a digital brain connected to pharmaceutical research, precision psychiatry, biomarkers, and advanced artificial intelligence technologies.

AI in neuroscience is driving big pharma investment. Discover how AI neuroscience platforms are driving precision psychiatry and psychedelic therapeutics.

Nicole Dale

Data Integrity and ALCOA Principles in Pharma Manufacturing

Pharmatica image representing ALCOA+ data integrity principles for pharmaceutical manufacturing and life sciences documentation, shown with glowing data connections.

Data integrity and ALCOA principles are under new pressure as digital twins, AI, and continuous manufacturing reshape pharma production and quality control.

Nicole Dale

RNA Biosensors for Real-Time Diabetes Detection and Monitoring

Realistic Pharmatica image of an RNA biosensor device with glowing yellow RNA helix on microchip, symbolising advanced molecular diagnostics, AI‑powered diabetes monitoring, and precision digital healthcare.

RNA biosensors for diabetes could allow earlier diagnosis and better personalised care. Explore the power of AI monitoring and next-generation molecular diagnostics.

Nicole Dale

GLP-1 Drug Discovery Success Transformed Pharmaceutical R&D

Pharmatica photorealistic illustration of GLP-1 drug discovery showing peptide molecules, metabolic signalling pathways, and obesity treatment research in a modern pharmaceutical laboratory.

From gut hormones to global therapeutics, GLP-1 drug discovery transformed obesity treatment through peptide engineering and incretin biology translation.

Nicole Dale

FDA Generic Peptides Guidance Sets New Expectations

Pharmatica visual of the FDA generic peptides guidance showing peptide molecular structure and regulatory assessment of generic peptide medicines.

Revised FDA draft guidance for generic peptide products updates expectations for ANDAs, impurities, structure, immune response, and biological activity.

Shubhangi Dua

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."